Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |